| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.005 |